Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: J Diabetes Complications. 2023 Dec 29;38(2):108669. doi: 10.1016/j.jdiacomp.2023.108669

Figure 1.

Figure 1.

Distribution of Responses to ED Single Item Proxy Overall and by Diabetes Status

* 9 (1.6%) additional participants added to cohort of participants with ED based on criteria of PDE5-Inhibitor use